Terms: = Germ cell tumor AND MYB, c-myb_CDS, 4602, ENSG00000118513, P10242, efg, Cmyb, c-myb AND Treatment
41 results:
1. DIPG-like myb-altered diffuse astrocytoma with durable response to intensive chemotherapy.
Trkova K; Sumerauer D; Krskova L; Vicha A; Koblizek M; Votava T; Priban V; Zapotocky M
Childs Nerv Syst; 2023 Sep; 39(9):2509-2513. PubMed ID: 37165121
[TBL] [Abstract] [Full Text] [Related]
2. myb Repression Mediates Stat5b-knockdown-induced Apoptosis and Inhibits Proliferation of Glioblastoma Stem cells.
Moyama C; Fujita M; Okamoto H; Ii H; Nakata S
Cancer Genomics Proteomics; 2023; 20(2):195-202. PubMed ID: 36870690
[TBL] [Abstract] [Full Text] [Related]
3. Knockdown MTDH Inhibits Glioma Proliferation and Migration and Promotes Apoptosis by Downregulating mybL2.
Fu J; Peng J; Tu G
Mediators Inflamm; 2022; 2022():1706787. PubMed ID: 36133745
[TBL] [Abstract] [Full Text] [Related]
4. The landscape of common genetic drivers and DNA methylation in low-grade (epilepsy-associated) neuroepithelial tumors: A review.
Jesus-Ribeiro J; Rebelo O; Ribeiro IP; Pires LM; Melo JD; Sales F; Santana I; Freire A; Melo JB
Neuropathology; 2022 Dec; 42(6):467-482. PubMed ID: 35844095
[TBL] [Abstract] [Full Text] [Related]
5. The 2021 WHO Classification of tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
Bale TA; Rosenblum MK
Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
[TBL] [Abstract] [Full Text] [Related]
6. [Pediatric Hemispheric Glioma].
Nakano Y; Ichimura K; Sakamoto H
No Shinkei Geka; 2022 Jan; 50(1):122-131. PubMed ID: 35169092
[TBL] [Abstract] [Full Text] [Related]
7. Angiocentric glioma: A case report and review of the literature.
Wang H; Zhu J; Zhu P; Luo C
J Clin Neurosci; 2021 Dec; 94():179-185. PubMed ID: 34863434
[TBL] [Abstract] [Full Text] [Related]
8. B-myb participated in ionizing radiation-induced apoptosis and cell cycle arrest in human glioma cells.
Shen X; Cao H; Zhu Y; Zhao Y; Liu Y; Zuo W; Lin F; Liang Z
Biochem Biophys Res Commun; 2021 Oct; 573():19-26. PubMed ID: 34375765
[TBL] [Abstract] [Full Text] [Related]
9. Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas.
Lazow MA; Hoffman L; Schafer A; Osorio DS; Boué DR; Rush S; Wright E; Lane A; DeWire-Schottmiller MD; Smolarek T; Sipple J; Taggert H; Reuss J; Salloum R; Hummel TR; de Blank P; Pillay-Smiley N; Sutton ME; Asher A; Stevenson CB; Drissi R; Finlay JL; Fouladi M; Fuller C
Acta Neuropathol Commun; 2020 Nov; 8(1):182. PubMed ID: 33153497
[TBL] [Abstract] [Full Text] [Related]
10. Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case report.
Williams SG; Aw Yeang HX; Mitchell C; Caramia F; Byrne DJ; Fox SB; Haupt S; Schittenhelm RB; Neeson PJ; Haupt Y; Keam SP
BMC Urol; 2020 Oct; 20(1):171. PubMed ID: 33115461
[TBL] [Abstract] [Full Text] [Related]
11. Integrated regulatory models for inference of subtype-specific susceptibilities in glioblastoma.
Liu Y; Shi N; Regev A; He S; Hemann MT
Mol Syst Biol; 2020 Sep; 16(9):e9506. PubMed ID: 32974985
[TBL] [Abstract] [Full Text] [Related]
12. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.
Lake JA; Donson AM; Prince E; Davies KD; Nellan A; Green AL; Mulcahy Levy J; Dorris K; Vibhakar R; Hankinson TC; Foreman NK; Ewalt MD; Kleinschmidt-DeMasters BK; Hoffman LM; Gilani A
Pediatr Blood Cancer; 2020 Jan; 67(1):e28028. PubMed ID: 31595628
[TBL] [Abstract] [Full Text] [Related]
13. MYCN is amplified during S phase, and c‑myb is involved in controlling MYCN expression and amplification in MYCN‑amplified neuroblastoma cell lines.
Aygun N; Altungoz O
Mol Med Rep; 2019 Jan; 19(1):345-361. PubMed ID: 30483774
[TBL] [Abstract] [Full Text] [Related]
14. Isolation and characterization of circulating melanoma cells by size filtration and fluorescent in-situ hybridization.
Yanagita M; Luke JJ; Hodi FS; Jänne PA; Paweletz CP
Melanoma Res; 2018 Apr; 28(2):89-95. PubMed ID: 29406397
[TBL] [Abstract] [Full Text] [Related]
15. Metastatic Adenoid Cystic Carcinoma Mimicking Butterfly Glioblastoma: A Rare Presentation in the Splenium of the Corpus Callosum.
Garber ST; Khoury L; Bell D; Schomer DF; Janku F; McCutcheon IE
World Neurosurg; 2016 Nov; 95():621.e13-621.e19. PubMed ID: 27521725
[TBL] [Abstract] [Full Text] [Related]
16. Hsa-miR-495 acts as a tumor suppressor gene in glioma via the negative regulation of myb.
Zhang B; Yuan F; Liu J; Li Y; Zhou F; Liu X; Hao Z; Li Q; Zheng Y; Wang W
Mol Med Rep; 2016 Jul; 14(1):977-82. PubMed ID: 27220777
[TBL] [Abstract] [Full Text] [Related]
17. Myths in the Diagnosis and Management of Orbital tumors.
Gündüz K; Yanık Ö
Middle East Afr J Ophthalmol; 2015; 22(4):415-20. PubMed ID: 26692710
[TBL] [Abstract] [Full Text] [Related]
18. New strategies in pediatric gliomas: molecular advances in pediatric low-grade gliomas as a model.
Raabe E; Kieran MW; Cohen KJ
Clin Cancer Res; 2013 Sep; 19(17):4553-8. PubMed ID: 23881924
[TBL] [Abstract] [Full Text] [Related]
19. Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma.
Requena C; Rubio L; Traves V; Sanmartín O; Nagore E; Llombart B; Serra C; Fernández-Serra A; Botella R; Guillén C
Histopathology; 2012 Nov; 61(5):899-909. PubMed ID: 22882594
[TBL] [Abstract] [Full Text] [Related]
20. A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-myb/MYCN axis in neuroblastoma.
Sottile F; Gnemmi I; Cantilena S; D'Acunto WC; Sala A
Oncotarget; 2012 May; 3(5):535-45. PubMed ID: 22619121
[TBL] [Abstract] [Full Text] [Related]
[Next]
